Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
iBio, Inc. roe for the quarter ending 2026-06-30 was -38.55%, a change of 84.95% year-over-year.
iBio, Inc. roe for the quarter ending 2026-03-31 was -35.60%, a change of 148.84% year-over-year.
iBio, Inc. roe for the quarter ending 2025-12-31 was -43.74%, a change of 95.18% year-over-year.
iBio, Inc. roe for the quarter ending 2025-09-30 was -35.88%, a change of 94.51% year-over-year.
iBio, Inc. roe for fiscal 2026 was -38.55%, a change of 84.95% from fiscal 2025.
iBio, Inc. roe for fiscal 2025 was -123.50%, a change of -6.70% from fiscal 2024.
iBio, Inc. roe for fiscal 2024 was -116.80%, a change of 305.86% from fiscal 2023.
iBio, Inc. roe for fiscal 2023 was -422.66%, a change of -343.43% from fiscal 2022.